Badalona Major Depressive Disorder Database Study
Completed
- Conditions
- Major Depressive Disorder
- Registration Number
- NCT01446692
- Lead Sponsor
- AstraZeneca
- Brief Summary
A retrospective study using a data base of anonymized medical records. The purpose of the study is to examine the different therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care
- Detailed Description
Therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care: the Badalona database study
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2260
Inclusion Criteria
- An International Classification of Primary Care (ICPC-2) or DSM-IV-TR diagnosis for major depressive disorder (MDD)
- At least 8 weeks of antidepressant treatment during the identification period of 01 January 2008 - 31 December 2009
- 18 months of enrollment with medical and pharmacy records after index episode date
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Description of the antidepressant strategies switches 18 months Number and type of treatment changes including combination, switch, or augmentation strategies.
- Secondary Outcome Measures
Name Time Method Health care costs 18 months Hamilton Depression Rating Scale 18 months Medication possession rate to evaluate adherence 18 months Health care resource utilization 18 months Referral to psychiatrist office 18 months
Trial Locations
- Locations (1)
Research Site
🇪🇸Badalona, Spain